About Molecular Cancer Research
Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.
Molecular Cancer Research welcomes submissions of primary research, review and commentary article types as well as letters to the editor. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.
The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Information for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal.
Submitting authors must be familiar with the Editorial Policies of the AACR Journals covering important information on authorship, publishing ethics, availability of materials and data and data analysis and reporting.
Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication. Please note that Molecular Cancer Research does not consider appeals.
For detailed metrics about Molecular Cancer Research and the other AACR journals see AACR Journals Metrics.
Editorial oversight of Molecular Cancer Research and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Boardwith support from journal staff. See Editorial Board for more information.
Material published in Molecular Cancer Research is covered and protected by copyright. Authors who wish to publish in the journal must formally transfer copyright to the AACR, but are granted considerable reuse rights. The final typeset version of every published article is rendered freely accessible 12 months after publication. Authors who prefer for their article to be immediately freely accessible online may make this selection by paying an additional fee through the AACR AuthorChoice option. In addition, the AACR assists authors in satisfying major funder Open Access archiving mandates by depositing the accepted author version of their article in a designated public repository. For additional details about all these topics, see Copyright, Permissions and Access.
To defray publication costs and to support other AACR programs, publication in Molecular Cancer Research involves the payment of a fixed publication fee and an additional fee for any color figures. If no financial support exists, authors may apply for a waiver of the fixed publication fee at the time of submission. See Publication Fees for further details.
Molecular Cancer Research (MCR) (Print ISSN: 1541-7786; Online ISSN 1557-3125) is published monthly, one volume/year, by the American Association for Cancer Research, Inc. (AACR).
Molecular Cancer Research is abstracted and/or indexed in BIOSIS Previews (R) Database, MEDLINE, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science.
Back Issues and Single Copy Sales
Subject to availability, single or back issues of Clinical Research may be purchased for $60 per copy in the U.S. or $65 per copy outside the U.S. For more information, contact:
AACR Publications Sales & Marketing Department
American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
Toll Free: (855) 744-4667 or (215) 440-9300
Molecular Cancer Research Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 440-9411 | E-mail: firstname.lastname@example.org